US FDA Denies Emergency Use Approval to Bharat Biotech's Covaxin
Without being approved by the WHO or the FDA, Covaxin is unlikely to be accepted as a legitimate vaccine by many countries.
Source: thewire.in
Page 17 - Master File News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Master File. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Master File Today - Breaking & Trending Today
Coronavirus News LIVE Updates: States Must Now Focus on Second Dose for Healthcare, Frontline Workers, Says Govt
Ocugen, the US partner of Bharat Biotech claimed the company will now be seeking full approval of Covaxin.
Source: msn.com
Coronavirus News LIVE Updates: Weekly Positivity Rate Less Than 5% in 15 States, 74% Drop Since Peak, Says Govt
Ocugen, the US partner of Bharat Biotech claimed the company will now be seeking full approval of Covaxin.
Source: msn.com
After FDA's Recommendation, Ocugen To Seek Full Approval For Bharat Biotech's Covaxin In US
The FDA has recommended that recommended Ocugen pursue a BLA submission instead of an EUA application for Covaxin.
Source: swarajyamag.com
FDA declines Covaxin's proposal for EUA: Vaccine Nationalism at play?
USFDA last month came out with a revised guideline for covid vaccine approval that said it will no longer grant emergency authorization to new applications. In some countries, people vaccinated with both the doses of Covaxin have been treated as unvaccinated.
Source: newsx.com